Home/Filings/4/0001387131-21-009686
4//SEC Filing

BONDERMAN DAVID 4

Accession 0001387131-21-009686

CIK 0001865975other

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 4:17 PM ET

Size

11.5 KB

Accession

0001387131-21-009686

Insider Transaction Report

Form 4
Period: 2021-09-25
Transactions
  • Other

    Class F Ordinary Shares

    2021-09-25+937,5006,050,000 total(indirect: See Explanation of Responses)
    Class A Ordinary Shares (937,500 underlying)
Footnotes (4)
  • [F1]On September 25, 2021, AfterNext HealthTech Sponsor, Series LLC ("AfterNext HealthTech Sponsor") forfeited at no cost 937,500 Class F Ordinary Shares, par value $0.0001 per share (the "Class F Shares"), of AfterNext HealthTech Acquisition Corp. (the "Issuer") in connection with the election by the underwriters of the Issuer's initial public offering to decline to exercise an option granted to them to cover over-allotments. Pursuant to the Issuer's Memorandum and Articles of Association, as amended, the Class F Shares will automatically convert into Class A Ordinary Shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's initial business combination on a one-for-one basis, subject to adjustment.
  • [F2]David Bonderman and James G. Coulter are sole shareholders of TPG Group Holdings (SBS) Advisors, Inc. (together with Messrs. Bonderman and Coulter, the "Reporting Persons"), which is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole shareholder of TPG Holdings III-A, Inc., which is the general partner of TPG Holdings III-A, L.P., which is the general partner of TPG Holdings III, L.P., which is the sole member of TPG HealthTech Governance, LLC, which is the managing member of AfterNext HealthTech Sponsor.
  • [F3]Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of AfterNext HealthTech Sponsor. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
  • [F4]Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Issuer

AfterNext HealthTech Acquisition Corp.

CIK 0001865975

Entity typeother

Related Parties

1
  • filerCIK 0000860866

Filing Metadata

Form type
4
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:17 PM ET
Size
11.5 KB